Daycare Attendance is Linked to Increased Risk of Respiratory Morbidities in Children Born Preterm with Bronchopulmonary Dysplasia.
bronchopulmonary dysplasia
daycare
rehospitalizations
respiratory morbidities
Journal
The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
received:
04
03
2022
revised:
06
05
2022
accepted:
05
06
2022
pubmed:
9
7
2022
medline:
13
10
2022
entrez:
8
7
2022
Statut:
ppublish
Résumé
To test the hypothesis that daycare attendance among children with bronchopulmonary dysplasia (BPD) is associated with increased chronic respiratory symptoms and/or greater health care use for respiratory illnesses during the first 3 years of life. Daycare attendance and clinical outcomes were obtained via standardized instruments for 341 subjects recruited from 9 BPD specialty clinics in the US. All subjects were former infants born preterm (<34 weeks) with BPD (71% severe) requiring outpatient follow-up between 0 and 3 years of age. Mixed logistic regression models were used to test for associations. Children with BPD attending daycare were more likely to have emergency department visits and systemic steroid usage. Children in daycare up to 3 years of age also were more likely to report trouble breathing, having activity limitations, and using rescue medications when compared with children not in daycare. More severe manifestations were found in children attending daycare between 6 and 12 months of chronological age. In this study, children born preterm with BPD who attend daycare were more likely to visit the emergency department, use systemic steroids, and have chronic respiratory symptoms compared with children not in daycare, indicating that daycare may be a potential modifiable risk factor to minimize respiratory morbidities in children with BPD during the preschool years.
Identifiants
pubmed: 35803300
pii: S0022-3476(22)00617-5
doi: 10.1016/j.jpeds.2022.06.037
pmc: PMC10588550
mid: NIHMS1936712
pii:
doi:
Substances chimiques
Steroids
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
22-28.e1Subventions
Organisme : NHLBI NIH HHS
ID : K23 HL136851
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL114800
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL140572
Pays : United States
Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Références
PLoS Med. 2014 Jan 28;11(1):e1001596
pubmed: 24492409
J Pediatr. 2017 Sep;188:135-141.e2
pubmed: 28662947
J Allergy Clin Immunol. 2006 Oct;118(4):823-30
pubmed: 17030233
Pediatrics. 2010 Oct;126(4):632-7
pubmed: 20876173
Am J Respir Crit Care Med. 2001 Jun;163(7):1723-9
pubmed: 11401896
Pediatrics. 2005 Dec;116(6):1353-60
pubmed: 16322158
Pediatr Pulmonol. 2009 Nov;44(11):1093-9
pubmed: 19824048
Pediatrics. 2015 Apr;135(4):607-16
pubmed: 25733757
Am J Respir Crit Care Med. 2010 Jul 15;182(2):237-45
pubmed: 20378729
Respir Res. 2015 Sep 21;16:115
pubmed: 26392057
Pediatr Pulmonol. 2017 Apr;52(4):556-569
pubmed: 27740723
Circulation. 2015 Nov 24;132(21):2037-99
pubmed: 26534956
Pediatrics. 1991 Sep;88(3):527-32
pubmed: 1881733
Drugs. 1997;54 Suppl 1:1-4
pubmed: 9378072
N Engl J Med. 2016 Sep 1;375(9):871-8
pubmed: 27579637
Pediatrics. 2012 Jan;129(1):e60-7
pubmed: 22201153
Eur J Pediatr. 2022 Feb;181(2):539-547
pubmed: 34417646
Pediatr Pulmonol. 2021 Jun;56(6):1617-1625
pubmed: 33713587
Pediatr Pulmonol. 2013 Jun;48(6):579-86
pubmed: 23129398
J Pediatr. 2018 Dec;203:218-224.e3
pubmed: 30172426
Pediatr Allergy Immunol. 2020 Feb;31 Suppl 24:16-18
pubmed: 32017219
J Pediatr. 2004 Jun;144(6):799-803
pubmed: 15192629
PLoS One. 2015 Feb 04;10(2):e0117253
pubmed: 25651521
Pediatrics. 2014 Feb;133(2):e312-21
pubmed: 24420808